Search

everythinglearnresearchcommunity

for

Search:↓

Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.

Mitotane changes steroid breakdown, affecting cortisol availability.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

The patient's hair loss was likely not caused by beta blockers but possibly by stress or other factors.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Certain Dibenzo derivatives may help treat prostate cancer.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

The new compound may be a safer alternative to finasteride for prostate protection.

Spironolactone improved symptoms in women with hormonal imbalances and had few side effects.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Both treatment combinations improved hair growth similarly and were safe.

Clascoterone safely promotes hair growth similar to minoxidil.

CRF can cause hair loss, but blocking its receptors might prevent this.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Minoxidil base is preferred for hair loss treatment, but minoxidil sulfate may be an alternative for unresponsive patients.